​

Ensysce Biosciences (ENSC) Revenue & Revenue Breakdown

OverviewOwnershipFinancialsChart

Ensysce Biosciences Revenue Highlights

00

Ensysce Biosciences Revenue by Period

Ensysce Biosciences Revenue by Year

DateRevenueChange
2024-12-31--100.00%
2023-12-31$2.23M-11.61%
2022-12-31$2.52M-28.54%
2021-12-31$3.53M-10.18%
2020-12-31$3.93M122.86%
2019-12-31$1.76M100.00%
2018-12-31-100.00%
2017-12-31--

Ensysce Biosciences generated - in revenue during NA 2024, up -100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Ensysce Biosciences Revenue by Quarter

DateRevenueChange
2025-09-30--100.00%
2025-06-30$1.37M3.90%
2025-03-31$1.32M1.23%
2024-12-31$1.30M-61.86%
2024-09-30$3.42M1780.59%
2024-06-30$181.80K-40.54%
2024-03-31$305.72K-40.64%
2023-12-31$515.03K18.29%
2023-09-30$435.38K-11.23%
2023-06-30$490.47K-37.89%
2023-03-31$789.63K-44.90%
2022-12-31$1.43M412.97%
2022-09-30$279.35K34.65%
2022-06-30$207.47K-65.60%
2022-03-31$603.10K-63.11%
2021-12-31$1.64M36.14%
2021-09-30$1.20M170.18%
2021-06-30$444.52K77.40%
2021-03-31$250.58K-39.84%
2020-12-31$416.49K-49.68%
2020-09-30$827.64K100.00%
2020-06-30--100.00%
2020-03-31$862.40K100.00%
2019-12-31-100.00%
2019-09-30-100.00%
2019-06-30-100.00%
2019-03-31-100.00%
2018-12-31-100.00%
2018-09-30-100.00%
2018-06-30-100.00%
2018-03-31-100.00%
2017-12-31-100.00%
2017-09-30--

Ensysce Biosciences generated - in revenue during Q3 2025, up -100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Ensysce Biosciences Revenue Breakdown

Ensysce Biosciences Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 23Dec 22
M P A R-$2.01M

Quarterly Revenue by Product

Product/ServiceSep 25Jun 25Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22
MPAR$493.10K$1.37M$119.94K$437.26K$481.28K---
M P A R-----$1.30M--
OUD------$73.06K$207.47K

Ensysce Biosciences's latest quarterly revenue breakdown by segment (product or service), as of Sep 25: MPAR (100.00%).

Ensysce Biosciences Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
XBIOXenetic Biosciences$2.50M$1.03M
VYNEVYNE Therapeutics$501.00K$169.00K
SNGXSoligenix$119.37K-
KZIAKazia Therapeutics$555.00$5.00
ENSCEnsysce Biosciences--
KALAKALA BIO--
TTNPTitan Pharmaceuticals--

ENSC Revenue FAQ

What is Ensysce Biosciences’s yearly revenue?

Ensysce Biosciences's yearly revenue for 2024 was $0, representing a decrease of -100.00% compared to 2023. The company's yearly revenue for 2023 was $2.23M, representing a decrease of -11.61% compared to 2022. ENSC's yearly revenue for 2022 was $2.52M, representing a decrease of -28.54% compared to 2021.

What is Ensysce Biosciences’s quarterly revenue?

Ensysce Biosciences's quarterly revenue for Q3 2025 was $0, a -100.00% decrease from the previous quarter (Q2 2025), and a -100.00% decrease year-over-year (Q3 2024). The company's quarterly revenue for Q2 2025 was $1.37M, a 3.90% increase from the previous quarter (Q1 2025), and a 654.38% increase year-over-year (Q2 2024). ENSC's quarterly revenue for Q1 2025 was $1.32M, a 1.23% increase from the previous quarter (Q4 2024), and a 331.76% increase year-over-year (Q1 2024).

What is Ensysce Biosciences’s revenue growth rate?

Ensysce Biosciences's revenue growth rate for the last 3 years (2022-2024) was -100.00%, and for the last 5 years (2020-2024) was -100.00%.